RecruitingNCT06645990

Early Left Ventricular unLoading by Impella vs Intra-aortic Balloon Pump

Early Left Ventricular unLoading by Impella (ECMELLA) or Intra-aortic Balloon Pump for Cardiogenic Shock in Patients on VA-ECMO


Sponsor

University Hospital, Montpellier

Enrollment

500 participants

Start Date

Jan 1, 2010

Study Type

OBSERVATIONAL

Conditions

Summary

Over the past decade, VA-ECMO has become the main mechanical support for cardiogenic shock (CS) unresponsive to medical therapy. However, recent studies failed to show any significant survival benefit at 30 days compared to medical treatment for myocardial infarction-related CS. This could be due to the complications of VA-ECMO, such as LV overload and increased LV distension, which can hinder heart recovery. To address this, early LV unloading using devices like IABP or Impella (ECMELLA) may help by reducing LV wall stress and oxygen consumption. However, these techniques carry risks, and their benefit is still unclear. A randomized trial is needed to compare these approaches, but observational studies are also contributing to understanding the best strategies


Eligibility

Min Age: 18 Years

Inclusion Criteria1

  • Adult patients (more than or =18 years) admitted for cardiogenic shock supported by ECMO+ IABP or ECMELLA between January 1, 2010, and December 31, 2023

Exclusion Criteria9

  • Ongoing extra-corporeal CardioPulmonary Resuscitation (eCPR) at time of ECMO implantation
  • Cardiogenic shock with previous prolonged continuous cardiopulmonary resuscitation (CPR) more than 30 minutes
  • Acute irreversible neurological injury
  • Previous known severe chronic cardiomyopathy (LVEF less than 25%) or awaiting heart transplantation or LVAD implantation
  • Contraindication to the implantation of an Impella or IABP
  • Mechanical complications of myocardial infarction
  • Moribund patient (SAPS more than 90)
  • Previous known severe chronic renal or hepatic failure
  • Age less than18 years

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEImpella

LV unloading with Impella (ECMELLA) before or within 24 h of ECMO initiation

DEVICEIABP

LV unloading with IABP before or within 24 h of ECMO initiation


Locations(1)

CHU Arnaud de Villeneuve

Montpellier, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06645990


Related Trials